BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25

• Press Releases

  RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026

  September 9, 2026

   · 

  1 min read
• Press Releases

  RadNet to Host Free Prostate Cancer Webinar on September 19, 2026

  September 9, 2026

   · 

  5 min read
• Press Releases

  Zomedica Announces “Fourth Friday at Four” Webinar on September 25, 2026: Inside Zomedica’s Marketing Engine: How Demand Becomes Revenue

  September 9, 2026

   · 

  8 min read
• Press Releases

  American Lung Association Puts a Spotlight on Clinical Trials and How They Can Offer Hope to People Living With Lung Cancer

  September 9, 2026

   · 

  4 min read
• Press Releases

  HanchorBio Reaches Clinical Milestone for HCB101 as US FDA Allows Continued Treatment for Phase 1 Patient Experiencing Clinical Benefit

  September 9, 2026

   · 

  4 min read
• Press Releases

  IDEAYA Biosciences and Servier Announce First Patient Dosed in OptimUM-11 Global Phase 3 Registrational Trial of Darovasertib and Crizotinib as Adjuvant Therapy for Subjects with Uveal Melanoma

  September 9, 2026

   · 

  9 min read
• Press Releases

  Navion Neurosciences Closes $10.8 Million Seed Financing to Advance Precision Sodium-Channel Medicines for Epilepsy and Neuropathic Pain

  September 9, 2026

   · 

  3 min read
• Press Releases

  Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery

  September 9, 2026

   · 

  6 min read
• 

  Regulatory

  Acting CBER, CDER heads become permanent as FDA works to restore stability

  The decision to promote Michael Davis and Karim Mikhail from acting to permanent division heads comes as the FDA awaits the potential confirmation of Heidi Overton, President Donald Trump’s nominee for commissioner.

  September 9, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  CAR-T

  BMS clinches pivotal win for myeloma CAR T in ‘key derisking event’

  Bristol Myers Squibb is positioning arlo-cel for quadruple-class exposed patients, which could help reduce competition with an upcoming multiple myeloma CAR T therapy from Gilead Sciences, according to BMO Capital Markets.

  September 9, 2026

   · 

  2 min read

   · 

  Tristan Manalac